Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(17 sites)
United States
City of Hope, Duarte, California University of Southern California, Los Angeles, California University of California, San Francisco, San Francisco, California University of Colorado School of Medicine, Aurora, Colorado University of Chicago, Chicago, Illinois